Biolidics Limited (SGX: 8YY)
0.0090
0.00 (0.00%)
At close: Sep 12, 2024
Biolidics Balance Sheet
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Cash & Equivalents | 0.15 | 0.18 | 5.03 | 3.96 | 10.67 | 6.03 | Upgrade
|
Cash & Short-Term Investments | 0.15 | 0.18 | 5.03 | 3.96 | 10.67 | 6.03 | Upgrade
|
Cash Growth | -94.66% | -96.36% | 26.99% | -62.88% | 76.95% | -47.56% | Upgrade
|
Accounts Receivable | 0.01 | 0.07 | 0.52 | 0.13 | 0.2 | 0.22 | Upgrade
|
Other Receivables | 0.07 | 0.03 | 0.13 | 0.19 | 0.09 | 0.06 | Upgrade
|
Receivables | 0.08 | 0.1 | 0.64 | 0.31 | 0.3 | 0.28 | Upgrade
|
Inventory | - | 0.01 | 0.03 | 1.51 | 1.61 | 0.9 | Upgrade
|
Prepaid Expenses | 0.06 | 0.08 | 0.18 | 0.29 | 0.27 | 0.39 | Upgrade
|
Other Current Assets | 0.18 | 0.05 | 0.04 | 0.04 | 0.1 | 0.11 | Upgrade
|
Total Current Assets | 0.46 | 0.43 | 5.92 | 6.11 | 12.95 | 7.72 | Upgrade
|
Property, Plant & Equipment | 0.08 | 0.25 | 0.17 | 1.19 | 1.41 | 1.34 | Upgrade
|
Goodwill | - | - | - | 0.63 | 0.63 | - | Upgrade
|
Other Intangible Assets | - | - | - | 3.5 | 3.78 | 0.57 | Upgrade
|
Total Assets | 0.55 | 0.68 | 6.09 | 11.42 | 18.76 | 9.62 | Upgrade
|
Accounts Payable | 0.02 | 0.02 | 0.09 | 0.09 | 0.14 | 0.52 | Upgrade
|
Accrued Expenses | - | 0.31 | 0.83 | 0.55 | 0.51 | 0.33 | Upgrade
|
Current Portion of Long-Term Debt | 0.98 | 1.08 | 1.05 | 1.02 | 0.87 | - | Upgrade
|
Current Portion of Leases | 0.09 | 0.2 | 0.21 | 0.25 | 0.26 | 0.14 | Upgrade
|
Current Unearned Revenue | 0.07 | 0.09 | 0.2 | 0.13 | 0.23 | 0.14 | Upgrade
|
Other Current Liabilities | 1.57 | 0.22 | 3.63 | 0.38 | 0.27 | 0.29 | Upgrade
|
Total Current Liabilities | 2.73 | 1.92 | 6.01 | 2.42 | 2.29 | 1.42 | Upgrade
|
Long-Term Debt | 0.18 | 0.61 | 1.69 | 2.74 | 3.76 | - | Upgrade
|
Long-Term Leases | 0.02 | 0.13 | 0.06 | 0.23 | 0.38 | 0.4 | Upgrade
|
Long-Term Unearned Revenue | - | - | - | - | - | 0.03 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | 0.48 | 0.53 | - | Upgrade
|
Other Long-Term Liabilities | - | 0.01 | 0.02 | 3.22 | 3.52 | 0 | Upgrade
|
Total Liabilities | 2.93 | 2.67 | 7.78 | 9.09 | 10.48 | 1.86 | Upgrade
|
Common Stock | 67.52 | 66.54 | 64.36 | 58.88 | 58.33 | 53.8 | Upgrade
|
Retained Earnings | -70 | -68.55 | -66.06 | -56.69 | -50.7 | -46.05 | Upgrade
|
Comprensive Income & Other | 0.09 | 0.02 | 0.01 | 0.13 | 0.64 | 0.02 | Upgrade
|
Total Common Equity | -2.39 | -1.99 | -1.69 | 2.33 | 8.27 | 7.77 | Upgrade
|
Shareholders' Equity | -2.39 | -1.99 | -1.69 | 2.33 | 8.27 | 7.77 | Upgrade
|
Total Liabilities & Equity | 0.55 | 0.68 | 6.09 | 11.42 | 18.76 | 9.62 | Upgrade
|
Total Debt | 1.27 | 2.02 | 3.01 | 4.25 | 5.28 | 0.54 | Upgrade
|
Net Cash (Debt) | -1.12 | -1.84 | 2.02 | -0.29 | 5.39 | 5.49 | Upgrade
|
Net Cash Growth | - | - | - | - | -1.81% | -52.23% | Upgrade
|
Net Cash Per Share | -0.00 | -0.00 | 0.01 | -0.00 | 0.02 | 0.02 | Upgrade
|
Filing Date Shares Outstanding | 744.76 | 744.76 | 559.13 | 265.45 | 264.05 | 242.5 | Upgrade
|
Total Common Shares Outstanding | 744.76 | 657.63 | 493.37 | 265.45 | 264.05 | 242.5 | Upgrade
|
Working Capital | -2.27 | -1.49 | -0.09 | 3.69 | 10.65 | 6.3 | Upgrade
|
Book Value Per Share | -0.00 | -0.00 | -0.00 | 0.01 | 0.03 | 0.03 | Upgrade
|
Tangible Book Value | -2.39 | -1.99 | -1.69 | -1.79 | 3.87 | 7.2 | Upgrade
|
Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.01 | 0.01 | 0.03 | Upgrade
|
Machinery | - | 2.97 | 2.97 | 3.05 | 2.82 | 2.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.